The Shifting Sands: JPMorgan Chimes In on Treace Medical, and It's a Sobering Note
Amidst Market Churn: The Enduring Stability of Cold Storage and Americold's Steady Outlook
A Whisper of Change: Decoding Wall Street's Latest Take on OFS Capital
The Shifting Sands of Biotech: Wall Street Zen Taps Puma Biotech's Roar Down a Notch
A Second Look? Wall Street Zen Shifts Stance on ECARX, Moving to a 'Hold'
The Biotech Beat: Why Wall Street's Whispers Are Turning to Crinetics
The Steady Hand: Why Fiserv's 'Neutral' Rating Isn't Budging
From Hold to High Hopes: Why Wall Street Just Elevated Tokio Marine's Status
Zen Technologies' Ascent: Why the Market is Watching, But Motilal Oswal Holds a 'Neutral' Card
Amara Raja Soars: Nuvama Reaffirms 'Buy' on New Energy Vision Post CFO Meeting
Aditya Birla Fashion & Retail: A Nuanced Look at Motilal Oswal's 'Neutral' Stance and Rs 100 Target
American Express Platinum: Navigating Fatigue for Future Growth
Micron Soars: AI Revolution Propels Stock to New Heights, Analyst Sees Massive Upside
Guggenheim Casts a 'Neutral' Eye on Immunocore's Future as Kimmtrak's Path Unfolds
Bank of America Reaffirms 'Buy' on Dell: Smooth CFO Transition Signals Continued Confidence in AI-Driven Growth
TransMedics: Stifel Initiates 'Hold' Amidst Innovation, Citing Valuation Concerns
IDEAYA Biosciences Ignites Investor Excitement with Dual "Buy" Ratings from Barclays and Citizens
Wells Fargo Crowns Axsome Therapeutics a Biotech Heavyweight with 'Overweight' Rating on Blockbuster Alzheimer's Potential
Amara Raja Batteries: Why Motilal Oswal Maintains a Neutral Stance Amidst Evolving Market Dynamics
NTPC's Power Play: Motilal Oswal Maintains 'Neutral' Stance with Rs 380 Target
Piper Sandler Initiates Bullish Coverage on Monday.com, Eyes Significant Upside